Galera develops small molecules targeting cancer vulnerabilities in tumor cells, in immune cells and in the tumor microenvironment, including superoxide dismutase (SOD) mimetics and nitric oxide synthase (NOS) inhibitors
Galera develops small molecules targeting cancer vulnerabilities in tumor cells, in immune cells and in the tumor microenvironment, including superoxide dismutase (SOD) mimetics and nitric oxide synthase (NOS) inhibitors.
Galera develops small molecules targeting cancer vulnerabilities in tumor cells, in immune cells and in the tumor microenvironment, including superoxide dismutase (SOD) mimetics and nitric oxide synthase (NOS) inhibitors
Galera develops small molecules targeting cancer vulnerabilities in tumor cells, in immune cells and in the tumor microenvironment, including superoxide dismutase (SOD) mimetics and nitric oxide synthase (NOS) inhibitors.